Inhibitors of pantothenate synthetase of Mycobacterium tuberculosis – a medicinal chemist perspective

Amaroju Suresh, Singireddi Srinivasarao, Yogesh Mahadu Khetmalis, Shashidhar Nizalapur, Murugesan Sankaranarayanan, Kondapalli Venkata Gowri Chandra Sekhar
2020 RSC Advances  
Tuberculosis, leads to numerous deaths worldwide. New drug discovery strategies are need of the hour. In the current review, we focused on the discovery of new antitubercular drugs targeting pantothenate synthetase.
doi:10.1039/d0ra07398a fatcat:5ky3oznorfcb7ecrarpnhrf6nm